ARS Pharmaceuticals (SPRY) Asset Utilization Ratio (2022 - 2026)
ARS Pharmaceuticals (SPRY) posted Asset Utilization Ratio of 0.32 for Q1 2026, up 33.72% sequentially from 0.24 in Q4 2025, and up 12.4% YoY from 0.29 in Q1 2025.
ARS Pharmaceuticals (SPRY) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
ARS Pharmaceuticals has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.32 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 12.4% year-over-year to 0.32 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.32 (up 12.4% YoY) and the FY2025 annual result came in at 0.25, down 18.62% from the prior year.
- Asset Utilization Ratio advanced to 0.32 in Q1 2026 per SPRY's latest filing, from 0.24 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.42 in Q3 2025 and troughed at 0.0 in Q1 2024.
- A 5-year average of 0.14 and a median of 0.01 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio sank 98.22% in 2024, then soared 659486.06% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.0 in 2022, then slumped by 97.39% to 0.0 in 2023, then jumped by 251602.23% to 0.31 in 2024, then slipped by 23.24% to 0.24 in 2025, then surged by 33.72% to 0.32 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.32, 0.24, and 0.42 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | ARS Pharmaceuticals | 561.88 Mn | 418.03 Mn | - | 0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.36 |
| Mar 31, 2026 | 0.32 |
| Dec 31, 2025 | 0.24 |
| Sep 30, 2025 | 0.42 |
| Jun 30, 2025 | 0.35 |
| Mar 31, 2025 | 0.29 |
| Dec 31, 2024 | 0.31 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |